Reuters logo
BRIEF-Alder Biopharmaceuticals Q3 loss per share $0.92
2017年11月7日 / 晚上10点09分 / 10 天前

BRIEF-Alder Biopharmaceuticals Q3 loss per share $0.92

Nov 7 (Reuters) - Alder Biopharmaceuticals Inc

* Alder biopharmaceuticals announces third quarter 2017 financial and operating results

* Q3 loss per share $0.92

* Q3 earnings per share view $-1.17 -- Thomson Reuters I/B/E/S

* Alder Biopharmaceuticals Inc - ‍eptinezumab biologics license application (BLA) submission on track for 2h18​

* Alder Biopharmaceuticals Inc - ‍promise 2 pivotal trial completed enrollment and top-line data on track for 1h18​

* Alder-Sees available cash & cash equivalents, short-term investments to be sufficient for projected requirements through late 2018/early 2019​‍​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below